Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease—A Pilot Study

Functional energetic responses and individual variance of the human brain revealed by quantitative imaging of adenosine triphosphate production rates

(2018) Xiao-Hong Zhu et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Drug Repurposing in Parkinson’s Disease

(2018) Dilan Athauda et al.   CNS DRUGS

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease

(2018) Simon M. Bell et al.   JOURNAL OF MOLECULAR BIOLOGY

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells

(2018) Amy M. Smith et al.   MOVEMENT DISORDERS

Interleaved 31 P MRS imaging of human frontal and occipital lobes using dual RF coils in combination with single-channel transmitter-receiver and dynamic B 0 shimming

(2017) Byeong-Yeul Lee et al.   NMR IN BIOMEDICINE

Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System

(2017) Kim L. Mertens et al.   Frontiers in Neuroscience

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

(2016) Patrick P. Michel et al.   NEURON

UDCA exerts beneficial effect on mitochondrial dysfunction inLRRK2G2019Scarriers and in vivo

(2015) Heather Mortiboys et al.   NEUROLOGY

Oxidative stress and Parkinson’s disease

(2015) Javier Blesa et al.   Frontiers in Neuroanatomy

Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson’s Disease: Modulation of Mitochondrial Perturbations

(2014) Noha F. Abdelkader et al.   MOLECULAR NEUROBIOLOGY

Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease

(2013) Heather Mortiboys et al.   BRAIN

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

(2012) Nicole Exner et al.   EMBO JOURNAL

Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease

(2012) M. Castro-Caldas et al.   MOLECULAR NEUROBIOLOGY

Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: A cross-sectional study of patients with Parkinson’s disease and related neurological conditions

(2012) Tariq Z Saleem et al.   PALLIATIVE MEDICINE

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis

(2010) Gareth J. Parry et al.   CLINICAL NEUROPHARMACOLOGY

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

(2008) Anthony HV Schapira   LANCET NEUROLOGY

Tauroursodeoxycholic Acid Partially Prevents Apoptosis Induced by 3-Nitropropionic Acid

(2003) Cecilia M. P. Rodrigues et al.   JOURNAL OF NEUROCHEMISTRY